Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 June 2019 | Story Ruan Bruwer | Photo Gerda Steyn Twitter
Gerda Steyn
Gerda Steyn, a former student at the University of the Free State, won her first Comrades race on Sunday, setting a new course record.

Winning the Comrades ultra-marathon is the greatest honour of her life and still feels unreal, said Gerda Steyn a day after winning the race in a record time.
 
The former Kovsie student had an incredible race on Sunday, completing the 86,83 km’s in a time of 05:58:54, which is a new record for women in the up run. It is more than 10 minutes faster than the previous record of 06:09:23 set in 2006.
 
It was also the fourth fastest Comrades time ever by a female in the 94-year history of the race.
 
Greatest honour of my life

 
“Being the Comrades winner is the greatest honour of my life. Thank you to an entire nation for carrying me to the line. It feels like a dream,” Steyn said.
 
The 29-year-old Steyn became the first woman in 30 years to win both the Comrades and Two Oceans in the same year. She also won the Two Oceans in 2018 and came second in the Comrades last year.
 
Steyn, who studied Quantity Surveying and Construction Management at the University of the Free State (UFS) between 2009 and 2012, said the record time was discussed beforehand.
 
I went for it
 
“We felt it was possible, but it wasn’t my main goal right from the start of the race. At the halfway mark, I saw it was possible and I went for it.”
 
According to Steyn, the media attention since her win is quite intense. “But I don’t complain. It is such an honour, so I do it with a smile.”
 
At the Two Oceans ultra-marathon in April, she missed out on the 30-year record time by just 53 seconds.
 
Prof Francis Petersen, UFS Rector and Vice-Chancellor, said Steyn was a proud ambassador of the university. “It is always important for me to see how our former students perform. I would like to congratulate her. Well done. She is carrying the Kovsie name with pride,” Prof Petersen said.
 

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept